The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
New article on the use and validity of child neurodevelopment outcome measures
July 12, 2019 7:24 PM
See a video abstract of the recently published systematic review on the use and validity of child neurodevelopent outcome measures in studies on prenatal exposure to psychotropic and analgesic medications.
New article on prenatal exposure to benzodiazepines and z-hypnotics
July 4, 2019 3:35 PM
New article by PharmaSafe researchers on the impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age.
European mega-venture for safe medications during pregnancy
June 11, 2019 2:34 PM
Professor Hedvig Nordeng is one of the researchers involved in the new and massive European research project ConcePTION, where the aim is to generate the knowledge that pregnant women want – and need – about the safety of medications.
2nd Neurogenesis Conference in Nassau, Bahamas, 2019
June 11, 2019 2:21 PM
Read the travel report from PhD students Nils A. Labba and Martin Falck.
PharmaTox at the NFIF conference 2019
June 11, 2019 2:08 PM
PharmaTox PhD students had several contributions to NFIF's annual conference.